We are live on ! Find out more
HMC

Harvard Management Company Portfolio holdings

AUM $4.26B
1-Year Est. Return 5.81%
This Fund
S&P 500
This Quarter Est. Return
+0.41%
1 Year Est. Return
+5.81%
3 Year Est. Return
+122.55%
5 Year Est. Return
+118.8%
10 Year Est. Return
+239.18%
AUM
$1.02B
AUM Growth
+$86.9M
Cap. Flow
+$87M
Cap. Flow %
8.56%
Top 10 Hldgs %
99.22%
Holding
12
New
2
Increased
1
Reduced
8
Closed
–

Top Buys

Rank Stock Value
1
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
+$77.5M
2
SVXY icon
ProShares Short VIX Short-Term Futures ETF
SVXY
+$10.2M
3
GLD icon
SPDR Gold Trust
GLD
+$194K

Top Sells

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$267K
2
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$194K
3
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$131K
4
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$108K
5
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$99K

Sector Composition

Rank Sector Weight
1 Miscellaneous 93.17%
2 Healthcare 6.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HYG icon
1
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.4B
$855M 84.18%
9,637,800
– –
KDNY
2
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$69.4M 6.83%
+1,303,620
New +$77.5M
IVV icon
3
iShares Core S&P 500 ETF
IVV
$875B
$21.3M 2.09%
84,099
-1,077
-1% -$267K
VEA icon
4
Vanguard FTSE Developed Markets ETF
VEA
$241B
$15.5M 1.53%
358,147
-3,096
-0.9% -$131K
SVXY icon
5
ProShares Short VIX Short-Term Futures ETF
SVXY
$258M
$11.3M 1.12%
+60,500
New +$10.2M
VWO icon
6
Vanguard FTSE Emerging Markets ETF
VWO
$129B
$9.77M 0.96%
224,120
-4,483
-2% -$194K
GLD icon
7
SPDR Gold Trust
GLD
$150B
$9.7M 0.95%
79,786
+1,595
+2% +$194K
IJH icon
8
iShares Core S&P Mid-Cap ETF
IJH
$126B
$5.38M 0.53%
150,300
-3,090
-2% -$108K
QQQ icon
9
Invesco QQQ Trust
QQQ
$490B
$5.25M 0.52%
36,122
-111
-0.3% -$15.9K
EDV icon
10
Vanguard World Funds Extended Duration ETF
EDV
$3.75B
$5.14M 0.51%
43,991
-15
-0% -$1.78K
IJR icon
11
iShares Core S&P Small-Cap ETF
IJR
$110B
$4.89M 0.48%
65,851
-1,412
-2% -$99K
VIG icon
12
Vanguard Dividend Appreciation ETF
VIG
$113B
$3.05M 0.3%
32,216
-68
-0.2% -$6.34K

Similar funds

MA
Marshfield Associates Washington, District of Columbia $4.26B AUM 12.94% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $4.27B AUM 45.92% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
DILIC
Dai-ichi Life Insurance Company Tokyo, Japan $4.28B AUM 43.07% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
HCC
Hill City Capital Boston, Massachusetts $4.28B AUM 80.76% 1-Year Est. Return
DWM
Destination Wealth Management Walnut Creek, California $4.28B AUM 19.27% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.24B AUM 4.82% 1-Year Est. Return

Harvard Management Company's Q3 2017 Portfolio in Review

As of Q3 2017, Harvard Management Company held 12 positions worth $1.02B, up 9.4% from $929M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

Harvard Management Company deployed $87M of net new capital in Q3 2017, opening 2 new positions and adding to 1 existing holding. Its largest new stake was Chinook Therapeutics, Inc. Common Stock: 1,303,620 shares worth $69.4M.

By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, down from 100% a quarter earlier, followed by Healthcare.

On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $267K trimmed.

  • Harvard Management Company's largest Q3 2017 buy was Chinook Therapeutics, Inc. Common Stock: 1,303,620 shares worth $69.4M.
  • Harvard Management Company added most to SPDR Gold Trust in Q3 2017, an estimated $194K increase.
  • Harvard Management Company's biggest Q3 2017 reduction was iShares Core S&P 500 ETF, cutting an estimated $267K.
  • Harvard Management Company's ten largest holdings make up 99% of its $1.02B portfolio in Q3 2017.
  • Harvard Management Company opened 2 new positions and closed 0 in Q3 2017.
  • Harvard Management Company's portfolio value rose 9.4% quarter-over-quarter to $1.02B.

Based on Harvard Management Company's 13F filing for Q3 2017, filed 9 Nov 2017.